Start with what you need treated.

Hair glossing treatments coat the hair shaft with a semi-permanent, shine-enhancing formula that smooths the cuticle layer, resulting in noticeably glossier, healthier-looking hair, and can also subtly enhance or refresh hair color tone. The gloss is applied to clean, towel-dried hair and typically left on for 10 to 20 minutes before rinsing, often combined with a hair coloring or highlighting service. The treatment takes about 30 to 45 minutes total in a salon setting with minimal preparation and no downtime. Hair appears visibly shinier and smoother immediately after treatment, with color-treated hair looking more vibrant and less brassy. Results typically last four to six weeks before gradually fading with washing, similar to a semi-permanent hair color. Regular glossing treatments help maintain consistent shine and color vibrancy between full coloring appointments.

Low-level laser therapy (LLLT) is a non-invasive treatment for pattern hair loss and thinning, using red or near-infrared light at a specific wavelength believed to stimulate cellular activity within hair follicles, increasing blood flow and potentially prolonging the hair growth phase. Treatment is typically delivered through a specialized cap, helmet, or comb device, either during in-clinic sessions or with an at-home device used several times per week. Each session usually takes 15 to 30 minutes and is completely painless, with no recovery time needed. Consistent, ongoing use over several months, typically at least four to six months, is needed before noticeable improvement in hair density is generally seen. This treatment is most effective for patients in the early stages of hair thinning and works best when combined with other hair loss treatments as part of a comprehensive approach. Results vary between individuals, and continued use is generally needed to maintain any improvement achieved.

Detox treatments use clarifying ingredients such as activated charcoal, clay, or specialized cleansing agents to thoroughly remove buildup from styling products, hard water minerals, and environmental pollutants that can accumulate on the hair and scalp over time, weighing hair down and dulling its appearance. The detoxifying formula is applied to the scalp and hair, sometimes combined with gentle exfoliation, and left on for 10 to 20 minutes before being rinsed thoroughly, often followed by a nourishing conditioner to replenish moisture. The treatment typically takes 45 minutes to an hour in a salon setting. Hair feels noticeably lighter, cleaner, and more voluminous immediately following treatment, with improved absorption of subsequently applied hair care products. Periodic detox treatments, roughly once a month, help maintain a healthy scalp environment, particularly for those who use styling products frequently or live in areas with hard water. This treatment provides an excellent reset before starting other more targeted hair treatments.

Bone marrow transplant, also called stem cell transplant, replaces a patient's diseased bone marrow with healthy stem cells, either from the patient's own body (autologous) or a matched donor (allogeneic), to treat conditions such as leukemia, lymphoma, multiple myeloma, or certain inherited blood disorders. The process begins with a conditioning regimen of high-dose chemotherapy or radiation to eliminate diseased cells and suppress the immune system, followed by infusion of the healthy stem cells through an intravenous line, similar to a blood transfusion. Patients require an extended hospital stay in a specialized, protected environment during the weeks following transplant while blood counts are very low and susceptibility to infection is high. Close monitoring for complications, including infection and graft-versus-host disease in allogeneic transplants, continues throughout recovery. Full immune system recovery can take several months to a year, with patients gradually resuming normal activities as blood counts and immunity improve. Successful transplant can offer long-term remission or cure for many underlying blood disorders.

Induction therapy is the first and most intensive phase of chemotherapy treatment for acute leukemia, designed to eliminate as many leukemic cells as possible and achieve complete remission, defined as no detectable leukemia cells in the bone marrow. Patients receive a combination of powerful chemotherapy drugs through an intravenous line over a period of days, typically requiring hospital admission due to the intensity of treatment and the need for close monitoring. During and after treatment, blood counts drop significantly, requiring supportive care including blood transfusions, growth factor injections, and antibiotics to prevent and treat infections during this vulnerable period. Bone marrow tests are performed after the initial treatment phase to assess whether remission has been achieved. Most patients require an extended hospital stay of several weeks while their blood counts recover to safe levels. Successful induction therapy sets the foundation for further consolidation treatment aimed at eliminating any remaining leukemic cells and achieving long-term remission.

Bone cancer treatment is individualized based on the specific type, such as osteosarcoma or Ewing sarcoma, its location, and stage, generally involving a combination of chemotherapy to shrink the tumor and address any microscopic spread, followed by surgery to remove the remaining tumor, often using limb-sparing techniques with prosthetic reconstruction rather than amputation when feasible. Radiation therapy may also be used for certain bone cancer types that are particularly sensitive to it, or when complete surgical removal is not possible. Chemotherapy is typically administered in cycles over several months, requiring periodic hospital visits or short admissions, while surgery involves a longer hospital stay and extensive rehabilitation afterward. A multidisciplinary team of oncologists, orthopedic surgeons, and radiation specialists coordinates the overall treatment plan tailored to each patient. Physical therapy plays a crucial role in recovery, particularly after limb-sparing surgery, to restore function and mobility. Long-term follow-up monitors for recurrence and manages any late effects of treatment.

Bone marrow cancer treatment depends on the specific diagnosis, which can include multiple myeloma, various forms of leukemia, or myelodysplastic syndromes, each requiring a distinct treatment approach based on the type of abnormal cells involved and how aggressively the disease is behaving. Treatment commonly involves chemotherapy and increasingly, targeted or immune-based therapies designed to attack cancer cells more precisely while sparing healthy tissue, sometimes followed by a bone marrow or stem cell transplant for eligible patients seeking the best chance of long-term remission. Treatment intensity and hospital stay requirements vary considerably, from outpatient oral or infusion therapies to intensive inpatient chemotherapy requiring weeks of hospitalization. Regular blood tests and bone marrow biopsies monitor treatment response and guide adjustments to the treatment plan over time. Supportive care, including management of infection risk, anemia, and bleeding tendencies, is an integral part of treatment throughout the course of therapy. Many patients achieve significant periods of remission with modern treatment approaches, and ongoing research continues to improve outcomes for these conditions.

Leukemia treatment is tailored to the specific subtype, whether acute or chronic, and myeloid or lymphocytic, since each behaves differently and responds to different treatment approaches. Acute leukemias typically require intensive chemotherapy given in phases, starting with induction therapy to achieve remission, followed by consolidation therapy to eliminate any remaining leukemic cells, often requiring extended hospital stays due to the intensity of treatment and resulting low blood counts. Chronic leukemias are often managed with oral targeted therapies on an outpatient basis, allowing many patients to continue relatively normal daily activities during treatment. For higher-risk or relapsed leukemia, a bone marrow or stem cell transplant may be recommended to achieve the best chance of long-term cure. Throughout treatment, supportive care including blood transfusions, infection prevention, and growth factor support helps manage the effects of chemotherapy on healthy blood cell production. Regular monitoring with blood tests and bone marrow examinations tracks response to treatment and guides ongoing management, with many patients achieving long-term remission or cure with modern treatment protocols.

Sickle cell anemia management combines preventive strategies with treatment of acute complications, since this inherited condition causes red blood cells to become misshapen and prone to blocking small blood vessels, leading to painful episodes called vaccine-occlusive crises and potential organ damage over time. Long-term management includes medications such as hydroxyurea to reduce the frequency of pain crises, folic acid supplementation to support red blood cell production, and vaccinations to reduce infection risk given the spleen dysfunction common in this condition. During acute pain crises, patients often require hospital admission for intravenous fluids, pain management, and sometimes blood transfusions to reduce the proportion of sickled cells in circulation. For eligible patients, particularly children with severe disease and a matched donor, bone marrow transplant offers the potential for cure, though it carries significant risks and is not suitable for everyone. Regular follow-up with a hematologist monitors for complications affecting organs such as the kidneys, lungs, and brain. With comprehensive, ongoing care, many patients with sickle cell anemia lead active lives with reduced frequency of complications.

Liver transplant is performed for patients with end-stage liver disease, acute liver failure, or certain liver cancers within specific criteria, where the liver's function has become so compromised that transplant offers the best chance of survival and quality of life. The diseased liver is completely removed and replaced with a healthy liver, either from a deceased donor or, increasingly, a portion of liver from a living donor, which regenerates to full size in both the donor and recipient over time. This is a major, complex surgery performed under general anesthesia, typically taking six to twelve hours. Patients require intensive post-operative care, initially in an intensive care unit, with lifelong immunosuppressive medication needed to prevent the body from rejecting the new organ. Close monitoring for rejection, infection, and medication side effects continues indefinitely, with more frequent follow-up in the early months after transplant. With modern surgical techniques and immunosuppression, the majority of liver transplant recipients achieve excellent long-term survival and quality of life.

Hepatitis B treatment focuses on suppressing the virus to low or undetectable levels to prevent ongoing liver inflammation and damage, using antiviral medications such as tenofovir or entecavir, taken as daily oral tablets, which are highly effective and generally well tolerated with a low risk of resistance developing. Not all patients with chronic hepatitis B require immediate treatment; the decision is based on viral load, liver enzyme levels, and evidence of liver damage assessed through blood tests and sometimes liver imaging or biopsy. Treatment is typically managed entirely on an outpatient basis, with regular blood tests every three to six months to monitor viral suppression, liver function, and screen for potential complications such as liver cancer. For most patients, treatment is long-term, sometimes lifelong, since stopping medication can allow the virus to reactivate. With consistent antiviral treatment, most patients achieve excellent control of the virus and a significantly reduced risk of progressing to cirrhosis or liver cancer. Family members are typically advised to be tested and vaccinated to prevent transmission.

In vitro fertilization (IVF) involves several coordinated steps over a treatment cycle: ovarian stimulation using hormone medications to encourage the development of multiple eggs, egg retrieval performed under light sedation using a needle guided by ultrasound, fertilization of the retrieved eggs with sperm in a laboratory setting, and finally transfer of the resulting embryo or embryos into the uterus. Each phase requires close monitoring through blood tests and ultrasounds to track follicle development and time procedures appropriately. The egg retrieval procedure itself is brief, taking about 20 to 30 minutes, performed as a day procedure with a short recovery period. Embryo transfer, typically performed a few days after retrieval or in a subsequent cycle using frozen embryos, is a quick, generally painless procedure not requiring anesthesia. Success rates vary based on factors including age, underlying cause of infertility, and embryo quality, with many patients requiring more than one cycle to achieve pregnancy. IVF has helped millions of couples worldwide overcome various causes of infertility to build their families.